A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Huntington's Disease A Study to Evaluate the Safety and Tolerability of SAGE-718in Participants With Huntington's Disease ...
A Phase 3, Multicenter, Open-label Safety Study to Evaluate the Long-term Safety and Tolerability of SAGE-718 in Participants With Huntington's Disease A Phase 3, Multicenter, Open-label Safety Study to Evaluate the Long-term Safety and Tolerability of ...
A Study to Evaluate the Effect of SAGE-718 on Functioning Capacity in Participants With Huntington's Disease A Study to Evaluate the Effect of SAGE-718on Functioning Capacity in Participants With Huntington's ...
A 28-Day Randomized, Placebo-Controlled, Double-Blind, Parallel Groups and Normative Comparison Study to Evaluate the Effect of SAGE-718 on Functioning Capacity in Participants With Huntington's Disease A 28-Day Randomized, Placebo-Controlled, Double-Blind, Parallel Groups and Normative Comparison Stud ...
A Study to Evaluate the Effect of SAGE-718 on Cognitive Function in Participants With Huntington's Disease (HD) A Study to Evaluate the Effect of SAGE-718on Cognitive Function in Participants With Huntington's Di ...
A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Effect of SAGE-718 on Cognitive Function in Participants With Huntington's Disease A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Effect of SAGE-718on Cognitive ...
A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of SAGE-718 Oral Solution in Patients With Huntington's Disease - Part B A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of SAGE-718Oral Solution in Patients ...
A Phase 1, Double-blind, Placebo-controlled, Multiple Ascending Dose Study to Determine the Safety, Tolerability, and Pharmacokinetics of SAGE-718 Oral Solution in Healthy Adults With an Open-label Cohort of Patients With Huntington's Disease A Phase 1, Double-blind, Placebo-controlled, Multiple Ascending Dose Study to Determine the Safety, ...